Details of the Drug Formulations

General Information of Drug (ID: DM6AUHV)

Drug Name
Fostamatinib Drug Info
Synonyms 901119-35-5; R788; Tavalisse; UNII-SQ8A3S5101; R-788 Free acid; R 788; R-788; R-935788 Free acid; SQ8A3S5101; R7935788; Fostamatinib [USAN:INN]
Indication
Disease Entry ICD 11 Status REF
Immune thrombocytopenic purpura 3B64.13 Approved [1]
Rheumatoid arthritis FA20 Phase 3 [2]
Cross-matching ID
PubChem CID
11671467
CAS Number
901119-35-5
TTD ID
D0V8HJ
VARIDT ID
DR00300
INTEDE ID
DR0754
ACDINA ID
D01107

Full List of Drug Formulations Containing This Drug

Fostamatinib 100 mg tablet
Company Formulation ID FDA Description
Rigel Pharmaceuticals F24308 Mannitol; Sodium Bicarbonate; Sodium Starch Glycolate; Povidone; Magnesium Stearate; Polyvinyl Alcohol; Titanium Dioxide; Polyethylene Glycol 3350; Talc; Iron Oxide Yellow; Iron Oxide Red
------------------------------------------------------------------------------------
Fostamatinib 150 mg tablet
Company Formulation ID FDA Description
Rigel Pharmaceuticals F24339 Mannitol; Sodium Bicarbonate; Sodium Starch Glycolate; Povidone; Magnesium Stearate; Polyvinyl Alcohol; Titanium Dioxide; Polyethylene Glycol 3350; Talc; Iron Oxide Yellow; Iron Oxide Red
------------------------------------------------------------------------------------

References

1 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7796).